View in EDS

A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine.

Saved in:
Bibliographic Details
Title: A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine.
Authors: Newbern EC; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Shoaibi A; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Haynes K; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Blacketer C; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Willame C; Janssen Research & Development, LLC, Turnhoutseweg 30, Beerse 2340, Belgium., DeFalco F; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Rao GA; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Davis K; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Velarde LA; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Praet N; Janssen Research & Development, LLC, Turnhoutseweg 30, Beerse 2340, Belgium., Makadia R; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Xu Y; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Ryan P; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States., Schuemie M; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States. Electronic address: mschuemi@its.jnj.com.
Source: Vaccine [Vaccine] 2025 May 10; Vol. 55, pp. 127044. Date of Electronic Publication: 2025 Mar 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40158304
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Newbern+EC%22">Newbern EC</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Shoaibi+A%22">Shoaibi A</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Haynes+K%22">Haynes K</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Blacketer+C%22">Blacketer C</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Willame+C%22">Willame C</searchLink>; Janssen Research & Development, LLC, Turnhoutseweg 30, Beerse 2340, Belgium.<br /><searchLink fieldCode="AU" term="%22DeFalco+F%22">DeFalco F</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Rao+GA%22">Rao GA</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Davis+K%22">Davis K</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Velarde+LA%22">Velarde LA</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Praet+N%22">Praet N</searchLink>; Janssen Research & Development, LLC, Turnhoutseweg 30, Beerse 2340, Belgium.<br /><searchLink fieldCode="AU" term="%22Makadia+R%22">Makadia R</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Ryan+P%22">Ryan P</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States.<br /><searchLink fieldCode="AU" term="%22Schuemie+M%22">Schuemie M</searchLink>; Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States. Electronic address: mschuemi@its.jnj.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2025 May 10; Vol. 55, pp. 127044. <i>Date of Electronic Publication: </i>2025 Mar 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40158304
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2025.127044
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 127044
    Titles:
      – TitleFull: A rapid cycle analytics framework for vaccine safety surveillance within a real-world data network: Experience with enhanced surveillance of the Janssen COVID-19 vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Newbern EC
      – PersonEntity:
          Name:
            NameFull: Shoaibi A
      – PersonEntity:
          Name:
            NameFull: Haynes K
      – PersonEntity:
          Name:
            NameFull: Blacketer C
      – PersonEntity:
          Name:
            NameFull: Willame C
      – PersonEntity:
          Name:
            NameFull: DeFalco F
      – PersonEntity:
          Name:
            NameFull: Rao GA
      – PersonEntity:
          Name:
            NameFull: Davis K
      – PersonEntity:
          Name:
            NameFull: Velarde LA
      – PersonEntity:
          Name:
            NameFull: Praet N
      – PersonEntity:
          Name:
            NameFull: Makadia R
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Ryan P
      – PersonEntity:
          Name:
            NameFull: Schuemie M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 05
              Text: 2025 May 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 55
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1